期刊文献+

New horizons in the endoscopic ultrasonography-based diagnosis of pancreatic cystic lesions 被引量:3

New horizons in the endoscopic ultrasonography-based diagnosis of pancreatic cystic lesions
下载PDF
导出
摘要 Pancreatic cystic lesions(PCLs) are increasingly being identified because of the widespread use of highresolution abdominal imaging. These cysts encompass a spectrum from malignant disease to benign lesions, and therefore, accurate diagnosis is crucial to determine the best management strategy, either surgical resection or surveillance. However, the current standard of diagnosis is not accurate enough due to limitations of imaging and tissue sampling techniques, which entail the risk of unnecessary burdensome surgery for benign lesions or missed opportunities of prophylactic surgery for potentially malignant PCLs. In the last decade, endoscopic innovations based on endoscopic ultrasonography(EUS) imaging have emerged, aiming to overcome the present limitations. These new EUS-based technologies are contrast harmonic EUS, needle-based confocal endomicroscopy, through-the-needle cystoscopy and through-the needle intracystic biopsy. Here, we present a comprehensive and critical review of these emerging endoscopic tools for the diagnosis of PCLs, with a special emphasis on feasibility, safety and diagnostic performance. Pancreatic cystic lesions(PCLs) are increasingly being identified because of the widespread use of highresolution abdominal imaging. These cysts encompass a spectrum from malignant disease to benign lesions, and therefore, accurate diagnosis is crucial to determine the best management strategy, either surgical resection or surveillance. However, the current standard of diagnosis is not accurate enough due to limitations of imaging and tissue sampling techniques, which entail the risk of unnecessary burdensome surgery for benign lesions or missed opportunities of prophylactic surgery for potentially malignant PCLs. In the last decade, endoscopic innovations based on endoscopic ultrasonography(EUS) imaging have emerged, aiming to overcome the present limitations. These new EUS-based technologies are contrast harmonic EUS, needle-based confocal endomicroscopy, through-the-needle cystoscopy and through-the needle intracystic biopsy. Here, we present a comprehensive and critical review of these emerging endoscopic tools for the diagnosis of PCLs, with a special emphasis on feasibility, safety and diagnostic performance.
出处 《World Journal of Gastroenterology》 SCIE CAS 2018年第26期2853-2866,共14页 世界胃肠病学杂志(英文版)
关键词 Intraductal papillary MUCINOUS neoplasm Pancreatic cystic lesions ENDOSCOPIC ULTRASONOGRAPHY Confocal endomicroscopy MUCINOUS CYSTADENOMA Through-the-needle cystoscopy Serous CYSTADENOMA Through-the-needle forceps biopsy Contrast harmonic ENDOSCOPIC ULTRASONOGRAPHY Intraductal papillary mucinous neoplasm Pancreatic cystic lesions Endoscopic ultrasonography Confocal endomicroscopy Mucinous cystadenoma Through-the-needle cystoscopy Serous cystadenoma Through-the-needle forceps biopsy Contrast harmonic endoscopic ultrasonography
  • 相关文献

参考文献2

二级参考文献48

  • 1Adsay NV, Fukushima N, Furukawa T, Hruban RH, Klimstra DH,Kl-ppel G, Offerhaus GJA, Pitman MB, Shimizu M, Zamboni G.Intraductal neoplasms of the pancreas. In: Bosman FT, CarneiroF, Hruban RH, Theise ND. WHO classification of tumors of thedigestive system. Lyon: IARC Press, 2010: 304-313.
  • 2Kobari M, Egawa S, Shibuya K, Shimamura H, SunamuraM, Takeda K, Matsuno S, Furukawa T. Intraductal papillarymucinous tumors of the pancreas comprise 2 clinical subtypes:differences in clinical characteristics and surgical management.Arch Surg 1999; 134: 1131-1136 [PMID: 10522860 DOI: 10.1001/archsurg.134.10.1131].
  • 3Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G,Bernades P, Belghiti J, Ruszniewski P, Fléjou JF. Intraductalpapillary mucinous tumors of the pancreas confined to secondaryducts show less aggressive pathologic features as compared withthose involving the main pancreatic duct. Am J Surg Pathol 2000;24: 1372-1377 [PMID: 11023098 DOI: 10.1097/00000478-200010000-00006].
  • 4Matsumoto T, Aramaki M, Yada K, Hirano S, Himeno Y, ShibataK, Kawano K, Kitano S. Optimal management of the branch ducttype intraductal papillary mucinous neoplasms of the pancreas.J Clin Gastroenterol 2003; 36: 261-265 [PMID: 12590239 DOI:10.1097/00004836-200303000-00014].
  • 5Lévy P, Jouannaud V, O'Toole D, Couvelard A, Vullierme MP,Palazzo L, Aubert A, Ponsot P, Sauvanet A, Maire F, Hentic O,Hammel P, Ruszniewski P. Natural history of intraductal papillarymucinous tumors of the pancreas: actuarial risk of malignancy.Clin Gastroenterol Hepatol 2006; 4: 460-468 [PMID: 16616351DOI: 10.1016/j.cgh.2006.01.018].
  • 6Kang MJ, Jang JY, Kim SJ, Lee KB, Ryu JK, Kim YT, YoonYB, Kim SW. Cyst growth rate predicts malignancy in patientswith branch duct intraductal papillary mucinous neoplasms. ClinGastroenterol Hepatol 2011; 9: 87-93 [PMID: 20851216 DOI:10.1016/j.cgh.2010.09.008].
  • 7Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, FalconiM, Shimizu M, Yamaguchi K, Yamao K, Matsuno S. Internationalconsensus guidelines for management of intraductal papillarymucinous neoplasms and mucinous cystic neoplasms of thepancreas. Pancreatology 2006; 6: 17-32 [PMID: 16327281 DOI:10.1159/000090023].
  • 8Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M,Jang JY, Kimura W, Levy P, Pitman MB, Schmidt CM, ShimizuM, Wolfgang CL, Yamaguchi K, Yamao K. International consensusguidelines 2012 for the management of IPMN and MCN of thepancreas. Pancreatology 2012; 12: 183-197 [PMID: 22687371DOI: 10.1016/j.pan.2012.04.004].
  • 9Kubo H, Chijiiwa Y, Akahoshi K, Hamada S, Harada N, Sumii T,Takashima M, Nawata H. Intraductal papillary-mucinous tumors ofthe pancreas: differential diagnosis between benign and malignanttumors by endoscopic ultrasonography. Am J Gastroenterol 2001;96: 1429-1434 [PMID: 11374678].
  • 10Kobayashi G, Fujita N, Noda Y, Ito K, Horaguchi J, TakasawaO, Akaishi S, Tsuchiya T, Kobari M. Mode of progression ofintraductal papillary-mucinous tumor of the pancreas: analysisof patients with follow-up by EUS. J Gastroenterol 2005; 40:744-751 [PMID: 16082592 DOI: 10.1007/s00535-005-1619-7].

共引文献18

同被引文献20

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部